[HTML][HTML] Systemic and mucosal immunogenicity of monovalent XBB. 1.5-adapted COVID-19 mRNA vaccines in patients with inflammatory bowel disease
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron
subvariant XBB. 1.5 and are recommended for patients with inflammatory bowel disease …
subvariant XBB. 1.5 and are recommended for patients with inflammatory bowel disease …
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4/5 variants in patients with inflammatory bowel disease treated with …
Background Anti-TNF drugs, such as infliximab, are associated with attenuated antibody
responses after SARS-CoV-2 vaccination. We aimed to determine how the anti-TNF drug …
responses after SARS-CoV-2 vaccination. We aimed to determine how the anti-TNF drug …
Neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of …
Z Liu, JL Alexander, K Le, X Zhou, H Ibraheim… - …, 2023 - thelancet.com
Background Patients with inflammatory bowel disease (IBD) receiving anti-TNF and JAK-
inhibitor therapy have attenuated responses to COVID-19 vaccination. We aimed to …
inhibitor therapy have attenuated responses to COVID-19 vaccination. We aimed to …
[HTML][HTML] A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy
TL Schell, F Caldera - Gastroenterology & Hepatology, 2024 - ncbi.nlm.nih.gov
The COVID-19 pandemic introduced significant uncertainty regarding the care of patients
with inflammatory bowel disease (IBD). Substantial research efforts have made progress in …
with inflammatory bowel disease (IBD). Substantial research efforts have made progress in …
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease
EJ Brenner, KN Weaver, X Zhang, AJ Kastl… - Clinical …, 2024 - Elsevier
Background and Aims COVID-19 vaccination prevents severe disease in most patients with
inflammatory bowel disease (IBD), but immunosuppressive medications can blunt serologic …
inflammatory bowel disease (IBD), but immunosuppressive medications can blunt serologic …
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ. 1.1 and XBB. 1.5 in patients with inflammatory bowel disease
S Woelfel, J Dütschler, M König… - Alimentary …, 2023 - Wiley Online Library
Background Vaccine‐elicited immune responses are impaired in patients with inflammatory
bowel disease (IBD) treated with anti‐TNF biologics. Aims To assess vaccination efficacy …
bowel disease (IBD) treated with anti‐TNF biologics. Aims To assess vaccination efficacy …
Antibody, not cellular, immune Responses to SARS-CoV-2 vaccination outperform infection in inflammatory bowel disease patients
From the* University of Oxford, Peter Medawar Building for Pathogen Research, Oxford,
United Kingdom† University Hospitals Leuven-KU Leuven, Department of Gastroenterology …
United Kingdom† University Hospitals Leuven-KU Leuven, Department of Gastroenterology …
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan
S Akiyama, H Shimizu, A Tamura… - Alimentary …, 2024 - Wiley Online Library
ABSTRACT Background Three Janus kinase (JAK) inhibitors are approved for ulcerative
colitis (UC) in Japan. Aim To compare the real‐world efficacy and safety of these three JAK …
colitis (UC) in Japan. Aim To compare the real‐world efficacy and safety of these three JAK …
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib
Z Liu, JL Alexander, K Yee Eng… - Journal of Crohn's …, 2024 - academic.oup.com
Abstract Background and Aims We sought to determine whether six commonly used
immunosuppressive regimens were associated with lower antibody responses after …
immunosuppressive regimens were associated with lower antibody responses after …
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data …
FS Macaluso, M Principi, F Facciotti… - Inflammatory Bowel …, 2024 - academic.oup.com
Materials and Methods Effectiveness and safety of COVID-19 vaccine in patients with
inflammatory bowel disease treated with immunomodulatory or biological drugs (ESCAPE …
inflammatory bowel disease treated with immunomodulatory or biological drugs (ESCAPE …